PH12014501211B1 - Deodorant composition - Google Patents
Deodorant composition Download PDFInfo
- Publication number
- PH12014501211B1 PH12014501211B1 PH12014501211A PH12014501211A PH12014501211B1 PH 12014501211 B1 PH12014501211 B1 PH 12014501211B1 PH 12014501211 A PH12014501211 A PH 12014501211A PH 12014501211 A PH12014501211 A PH 12014501211A PH 12014501211 B1 PH12014501211 B1 PH 12014501211B1
- Authority
- PH
- Philippines
- Prior art keywords
- copolymer
- component
- deodorant composition
- composition
- alkyl
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 94
- 239000002781 deodorant agent Substances 0.000 title claims abstract description 65
- 230000001166 anti-perspirative effect Effects 0.000 claims abstract description 80
- 239000003213 antiperspirant Substances 0.000 claims abstract description 80
- 229920001577 copolymer Polymers 0.000 claims abstract description 49
- 125000005250 alkyl acrylate group Chemical group 0.000 claims abstract description 45
- 229920006322 acrylamide copolymer Polymers 0.000 claims abstract description 36
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims abstract description 25
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 22
- OMNKZBIFPJNNIO-UHFFFAOYSA-N n-(2-methyl-4-oxopentan-2-yl)prop-2-enamide Chemical compound CC(=O)CC(C)(C)NC(=O)C=C OMNKZBIFPJNNIO-UHFFFAOYSA-N 0.000 claims abstract description 21
- 150000003839 salts Chemical class 0.000 claims abstract description 18
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims abstract description 15
- 229920006318 anionic polymer Polymers 0.000 claims abstract description 13
- 229920000800 acrylic rubber Polymers 0.000 claims abstract description 12
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 claims abstract description 7
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 claims abstract description 6
- -1 chlorohydroxyaluminum Chemical compound 0.000 claims description 42
- 125000000217 alkyl group Chemical group 0.000 claims description 28
- LDHQCZJRKDOVOX-NSCUHMNNSA-N crotonic acid Chemical compound C\C=C\C(O)=O LDHQCZJRKDOVOX-NSCUHMNNSA-N 0.000 claims description 16
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 claims description 14
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 14
- LDHQCZJRKDOVOX-UHFFFAOYSA-N trans-crotonic acid Natural products CC=CC(O)=O LDHQCZJRKDOVOX-UHFFFAOYSA-N 0.000 claims description 13
- 239000000499 gel Substances 0.000 claims description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 12
- XTXRWKRVRITETP-UHFFFAOYSA-N Vinyl acetate Chemical compound CC(=O)OC=C XTXRWKRVRITETP-UHFFFAOYSA-N 0.000 claims description 11
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical class OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 claims description 9
- 239000000377 silicon dioxide Substances 0.000 claims description 9
- TVFJAZCVMOXQRK-UHFFFAOYSA-N ethenyl 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC(=O)OC=C TVFJAZCVMOXQRK-UHFFFAOYSA-N 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 239000000454 talc Substances 0.000 claims description 6
- 229910052623 talc Inorganic materials 0.000 claims description 6
- IEPRKVQEAMIZSS-UHFFFAOYSA-N Di-Et ester-Fumaric acid Natural products CCOC(=O)C=CC(=O)OCC IEPRKVQEAMIZSS-UHFFFAOYSA-N 0.000 claims description 5
- IEPRKVQEAMIZSS-WAYWQWQTSA-N Diethyl maleate Chemical compound CCOC(=O)\C=C/C(=O)OCC IEPRKVQEAMIZSS-WAYWQWQTSA-N 0.000 claims description 5
- 239000003595 mist Substances 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical class CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- AMULJSVDIHMAOX-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate;prop-2-enoic acid Chemical compound OC(=O)C=C.OCCCOC(=O)C=C AMULJSVDIHMAOX-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- JBSLOWBPDRZSMB-FPLPWBNLSA-N dibutyl (z)-but-2-enedioate Chemical compound CCCCOC(=O)\C=C/C(=O)OCCCC JBSLOWBPDRZSMB-FPLPWBNLSA-N 0.000 claims 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 abstract description 7
- 125000004209 (C1-C8) alkyl group Chemical group 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 73
- 210000004243 sweat Anatomy 0.000 description 42
- 238000011156 evaluation Methods 0.000 description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 25
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 18
- 238000009472 formulation Methods 0.000 description 18
- 238000002360 preparation method Methods 0.000 description 17
- 230000001877 deodorizing effect Effects 0.000 description 13
- 238000013329 compounding Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- 239000003205 fragrance Substances 0.000 description 11
- 239000000047 product Substances 0.000 description 11
- 208000035985 Body Odor Diseases 0.000 description 10
- 206010040904 Skin odour abnormal Diseases 0.000 description 10
- 239000004615 ingredient Substances 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- QZPSOSOOLFHYRR-UHFFFAOYSA-N 3-hydroxypropyl prop-2-enoate Chemical compound OCCCOC(=O)C=C QZPSOSOOLFHYRR-UHFFFAOYSA-N 0.000 description 7
- 230000007774 longterm Effects 0.000 description 7
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 7
- 229920002554 vinyl polymer Polymers 0.000 description 7
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 6
- UTOVMEACOLCUCK-PLNGDYQASA-N butyl maleate Chemical compound CCCCOC(=O)\C=C/C(O)=O UTOVMEACOLCUCK-PLNGDYQASA-N 0.000 description 6
- 230000001629 suppression Effects 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 5
- 230000005923 long-lasting effect Effects 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 239000003513 alkali Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 4
- 235000014113 dietary fatty acids Nutrition 0.000 description 4
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 4
- 239000000194 fatty acid Substances 0.000 description 4
- 229930195729 fatty acid Natural products 0.000 description 4
- 150000004665 fatty acids Chemical class 0.000 description 4
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 4
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 4
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 4
- 239000004094 surface-active agent Substances 0.000 description 4
- NMGPHUOPSWFUEB-UHFFFAOYSA-N 2-(butylamino)ethyl 2-methylprop-2-enoate Chemical compound CCCCNCCOC(=O)C(C)=C NMGPHUOPSWFUEB-UHFFFAOYSA-N 0.000 description 3
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 3
- 239000004166 Lanolin Substances 0.000 description 3
- 229920002678 cellulose Polymers 0.000 description 3
- 239000001913 cellulose Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- UPBDXRPQPOWRKR-UHFFFAOYSA-N furan-2,5-dione;methoxyethene Chemical compound COC=C.O=C1OC(=O)C=C1 UPBDXRPQPOWRKR-UHFFFAOYSA-N 0.000 description 3
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 3
- 235000019388 lanolin Nutrition 0.000 description 3
- 229940039717 lanolin Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- WWZOVTMPZTWOAV-UHFFFAOYSA-N 2-aminoacetic acid;zirconium Chemical compound [Zr].NCC(O)=O WWZOVTMPZTWOAV-UHFFFAOYSA-N 0.000 description 2
- VSKJLJHPAFKHBX-UHFFFAOYSA-N 2-methylbuta-1,3-diene;styrene Chemical compound CC(=C)C=C.C=CC1=CC=CC=C1.C=CC1=CC=CC=C1 VSKJLJHPAFKHBX-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- VSCWAEJMTAWNJL-UHFFFAOYSA-K aluminium trichloride Chemical compound Cl[Al](Cl)Cl VSCWAEJMTAWNJL-UHFFFAOYSA-K 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 239000003212 astringent agent Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 239000003876 biosurfactant Substances 0.000 description 2
- 229920001400 block copolymer Polymers 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 238000010612 desalination reaction Methods 0.000 description 2
- FLKPEMZONWLCSK-UHFFFAOYSA-N diethyl phthalate Chemical compound CCOC(=O)C1=CC=CC=C1C(=O)OCC FLKPEMZONWLCSK-UHFFFAOYSA-N 0.000 description 2
- 229940008099 dimethicone Drugs 0.000 description 2
- 239000004205 dimethyl polysiloxane Substances 0.000 description 2
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 2
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 230000003405 preventing effect Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000009877 rendering Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000000106 sweat gland Anatomy 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- DUXYWXYOBMKGIN-UHFFFAOYSA-N trimyristin Chemical compound CCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCC DUXYWXYOBMKGIN-UHFFFAOYSA-N 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- VVMKVFQYONGBPV-MKWAYWHRSA-N (z)-4-butoxy-4-oxobut-2-enoic acid;methoxyethene Chemical compound COC=C.CCCCOC(=O)\C=C/C(O)=O VVMKVFQYONGBPV-MKWAYWHRSA-N 0.000 description 1
- UVHQXWILFGUDTA-LNKPDPKZSA-N (z)-4-ethoxy-4-oxobut-2-enoic acid;methoxyethene Chemical compound COC=C.CCOC(=O)\C=C/C(O)=O UVHQXWILFGUDTA-LNKPDPKZSA-N 0.000 description 1
- ZORQXIQZAOLNGE-UHFFFAOYSA-N 1,1-difluorocyclohexane Chemical compound FC1(F)CCCCC1 ZORQXIQZAOLNGE-UHFFFAOYSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- POAOYUHQDCAZBD-UHFFFAOYSA-N 2-butoxyethanol Chemical compound CCCCOCCO POAOYUHQDCAZBD-UHFFFAOYSA-N 0.000 description 1
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 1
- MUHFRORXWCGZGE-KTKRTIGZSA-N 2-hydroxyethyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCO MUHFRORXWCGZGE-KTKRTIGZSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- SATHPVQTSSUFFW-UHFFFAOYSA-N 4-[6-[(3,5-dihydroxy-4-methoxyoxan-2-yl)oxymethyl]-3,5-dihydroxy-4-methoxyoxan-2-yl]oxy-2-(hydroxymethyl)-6-methyloxane-3,5-diol Chemical compound OC1C(OC)C(O)COC1OCC1C(O)C(OC)C(O)C(OC2C(C(CO)OC(C)C2O)O)O1 SATHPVQTSSUFFW-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- YPIFGDQKSSMYHQ-UHFFFAOYSA-M 7,7-dimethyloctanoate Chemical compound CC(C)(C)CCCCCC([O-])=O YPIFGDQKSSMYHQ-UHFFFAOYSA-M 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000001904 Arabinogalactan Substances 0.000 description 1
- 229920000189 Arabinogalactan Polymers 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 229920004939 Cariflex™ Polymers 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- 235000017788 Cydonia oblonga Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- YTBSYETUWUMLBZ-QWWZWVQMSA-N D-threose Chemical compound OC[C@@H](O)[C@H](O)C=O YTBSYETUWUMLBZ-QWWZWVQMSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 229920002307 Dextran Polymers 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- WYUFTYLVLQZQNH-JAJWTYFOSA-N Ethyl beta-D-glucopyranoside Chemical compound CCO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O WYUFTYLVLQZQNH-JAJWTYFOSA-N 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- CMBYOWLFQAFZCP-UHFFFAOYSA-N Hexyl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OCCCCCC CMBYOWLFQAFZCP-UHFFFAOYSA-N 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 241001527806 Iti Species 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- JHWNWJKBPDFINM-UHFFFAOYSA-N Laurolactam Chemical compound O=C1CCCCCCCCCCCN1 JHWNWJKBPDFINM-UHFFFAOYSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 1
- 229920000299 Nylon 12 Polymers 0.000 description 1
- 240000008881 Oenanthe javanica Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004373 Pullulan Substances 0.000 description 1
- 229920001218 Pullulan Polymers 0.000 description 1
- 101150107341 RERE gene Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- HDYRYUINDGQKMC-UHFFFAOYSA-M acetyloxyaluminum;dihydrate Chemical compound O.O.CC(=O)O[Al] HDYRYUINDGQKMC-UHFFFAOYSA-M 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 229940037003 alum Drugs 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- 229940009827 aluminum acetate Drugs 0.000 description 1
- 229940063656 aluminum chloride Drugs 0.000 description 1
- 229940103272 aluminum potassium sulfate Drugs 0.000 description 1
- 229940010048 aluminum sulfate Drugs 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000019312 arabinogalactan Nutrition 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 235000013405 beer Nutrition 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000002738 chelating agent Substances 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 229960003067 cystine Drugs 0.000 description 1
- SASYSVUEVMOWPL-NXVVXOECSA-N decyl oleate Chemical compound CCCCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC SASYSVUEVMOWPL-NXVVXOECSA-N 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 239000010696 ester oil Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- LRBQNJMCXXYXIU-QWKBTXIPSA-N gallotannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@H]2[C@@H]([C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-QWKBTXIPSA-N 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000001727 glucose Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- YQEMORVAKMFKLG-UHFFFAOYSA-N glycerine monostearate Natural products CCCCCCCCCCCCCCCCCC(=O)OC(CO)CO YQEMORVAKMFKLG-UHFFFAOYSA-N 0.000 description 1
- SVUQHVRAGMNPLW-UHFFFAOYSA-N glycerol monostearate Natural products CCCCCCCCCCCCCCCCC(=O)OCC(O)CO SVUQHVRAGMNPLW-UHFFFAOYSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- GQXQIRNPJBUEGY-UHFFFAOYSA-N hexadecan-7-yl 2,2-dimethyloctanoate Chemical compound CCCCCCCCCC(CCCCCC)OC(=O)C(C)(C)CCCCCC GQXQIRNPJBUEGY-UHFFFAOYSA-N 0.000 description 1
- 229940100463 hexyl laurate Drugs 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229920001903 high density polyethylene Polymers 0.000 description 1
- 239000004700 high-density polyethylene Substances 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940074928 isopropyl myristate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 229940075495 isopropyl palmitate Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 229960000448 lactic acid Drugs 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229920000092 linear low density polyethylene Polymers 0.000 description 1
- 239000004707 linear low-density polyethylene Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940078812 myristyl myristate Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940059574 pentaerithrityl Drugs 0.000 description 1
- WXZMFSXDPGVJKK-UHFFFAOYSA-N pentaerythritol Chemical compound OCC(CO)(CO)CO WXZMFSXDPGVJKK-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 229920000259 polyoxyethylene lauryl ether Polymers 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- GRLPQNLYRHEGIJ-UHFFFAOYSA-J potassium aluminium sulfate Chemical compound [Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O GRLPQNLYRHEGIJ-UHFFFAOYSA-J 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- 235000019423 pullulan Nutrition 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 229920002050 silicone resin Polymers 0.000 description 1
- 239000002356 single layer Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019830 sodium polyphosphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 235000011069 sorbitan monooleate Nutrition 0.000 description 1
- 239000001593 sorbitan monooleate Substances 0.000 description 1
- 229940035049 sorbitan monooleate Drugs 0.000 description 1
- 235000011071 sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001570 sorbitan monopalmitate Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- DZKXJUASMGQEMA-UHFFFAOYSA-N tetradecyl tetradecanoate Chemical compound CCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCC DZKXJUASMGQEMA-UHFFFAOYSA-N 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229940045136 urea Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 229940118827 zinc phenolsulfonate Drugs 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
- BOVNWDGXGNVNQD-UHFFFAOYSA-L zinc;2-hydroxybenzenesulfonate Chemical compound [Zn+2].OC1=CC=CC=C1S([O-])(=O)=O.OC1=CC=CC=C1S([O-])(=O)=O BOVNWDGXGNVNQD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q15/00—Anti-perspirants or body deodorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8135—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an acyloxy radical of a saturated carboxylic acid, of carbonic acid or of a haloformic acid; Compositions of derivatives of such polymers, e.g. vinyl esters (polyvinylacetate)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8158—Homopolymers or copolymers of amides or imides, e.g. (meth) acrylamide; Compositions of derivatives of such polymers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
Abstract
Provided is a deodorant composition comprising: (A) an antiperspirant component, and (B-1) an acrylic acid-based anionic polymer selected from among an ammonium (styrene/alkyl acrylate) copolymer, an ammonium alkyl acrylate copolymer, an octylamide acrylate-hydroxypropyl acrylate-butylaminoethyl methacrylate copolymer, an (alkyl acrylate/diacetone acrylamide) copolymer-amodimethicone, an (acrylates/(C1-18)alkyl acrylate/(C1-8)alkyl acrylamide) copolymer or a salt thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof, wherein the ratio of the content of the component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.
Description
I ——————— ¥ } alkyl acrylate/(Cy-g) alkyl acrylamide) copolymers or salts thereof, and (alkyl acrylate/diacetone acrylamide) copolymers or salts thereof.
Examples of (acrylates/(Ci-13) alkyl acrylate/(Ci-s) alkyl acrylamide) copolymers or salts thereof include (acrylates/ (Ci-13) alkyl acrylate/ (Cis) alkyl acrylamide) copolymer AMP (chemical name: 2-amino-2-methyl-l-propanol salt of alkyl esters of acrylic acid and methacrylic acid /alkyl acrylate/acrylamide copolymer; trade name:
Plascize L-9909B, from Goo Chemical Co., Ltd.; 40 wt %).
Examples of (alkyl acrylate/diacetone acrylamide) copolymers or salts thereof (alkyl acrylate/diacetone acrylamide) copolymer-AMPD (chemical name : 2-amino-2-methyl-1, 3-propanediol salt of alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; trade name:
Plascize L-1260, from Goo Chemical Co., Ltd.; 40 wt %), (alkyl acrylate/diacetone acrylamide) copolymer AMP (chemical name: 2-amino-2-methyl-l-propanol salt of alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; Plascize L-53P, from Goo Chemical Co., Ltd.; 50 wt %), and (alkyl acrylate/diacetone acrylamide) copolymer (chemical name: alkyl acrylate/alkyl methacrylate/diacetone acrylamide/methacrylic acid copolymer; trade name:
Plascize L-53, from Goo Chemical Co., Ltd.; 50 wt %).
These may be used singly or two or more may be used in combination. However, from the standpoint of the antiperspirant effect, ammonium (styrene/alkyl acrylate) copolymer, (acrylates/ (Ci-18) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer AMP and octylamide acrylate/hydroxypropyl acrylate/butyl aminoethyl methacrylate copolymer are preferred. From the standpoint of the stability of the preparation, (acrylates/(Ci-1s)
EE EEE —————————————e 1 } alkyl acrylate/(Ci-s) alkyl acrylamide) copolymer AMP and octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate copolymer are especially preferred.
From the standpoint of the antiperspirant effect and the prevention of sweat stains on clothing, the content of component (B-1) is preferably from 0.1 to 2.5 wt %, and more preferably from 0.3 to 2 wt %, of the overall composition. At a component (B-1) content of less than 0.1 wt %, the antiperspirant effect, duration of the antiperspirant effect and absence of sweat stains on clothing may be inadequate. On the other hand, at a content greater than 2.5 wt %, stickiness may occur, making use less pleasant, in addition to which the stability (absence of separation and settling) of the preparation may decrease. (B-2) Vinyl Acetate-Based Anionic Polymer
Illustrative examples of vinyl acetate-based anionic polymers include (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer (trade name: RESYN 28-2930, from AkzoNobel Japan), (vinyl methyl ether/ethyl maleate) copolymer (trade name: Gantrez ES-225, from ISP Japan
KK), and (vinyl methyl ether/butyl maleate) copolymer (Gantrez ES-425, from ISP Japan KK). From the standpoint of the antiperspirant effect, the durability of this effect and the absence of sweat stains, a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer is especially preferred. From the standpoint of the stability of the preparation, a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer are especially preferred.
From the standpoint of the antiperspirant effect, the content of component {B-2) is preferably from 0.1 to 5 wt %, and more preferably from 1 to 4 wt %. At a component (B-2) content below 0.1 wt %, the antiperspirant effect, -g-
y x durability of the antiperspirant effect and absence of sweat stains on clothing may become inadequate. On the other hand, at more than 5 wt $%, stickiness may arise, making use less pleasant, in addition to which the stability (absence of clouding, absence of settling) of the preparation may decrease.
A commercial product (un-neutralized product or neutralized product) may be used directly without modification as the anionic polymer in this invention.
Commercial products which are un-neutralized products may ! be rendered into salts using any alkali agent, and commercial products which are neutralized products may be desalinated using any acid. No particular limitations are imposed on the alkali agent or the acid, although in the case of an alkali agent, rendering into a salt using ammonium, 2-amino-2-methyl-1l-propanol (AMP) , 2-amino-2- methyl-1, 3-propanediol (AMPD) or the like as the alkali agent is preferred; in the case of an acid, desalination using hydrochloric acid, sulfuric acid or the like is preferred. The method of desalination may entail, for example, dissolving 1 g of (acrylates/ (Ci-1g) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer AMP (Plascize
L9909B, 40 wt %) in 4 g of ethanol (95 wt %). By adding to this 65 pL of hydrochloric acid and desalinating, an (acrylates/ (Ci-13) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer (35 wt %) may be obtained. In this invention, salts obtained using 2-amino-2-methyl-1l-propanol are abbreviated AMP, and salts obtained using 2-amino-2-methyl- 1, 3-propanediol are abbreviated AMPD.
In this invention, the effect of imparting durability or water resistance to the skin with component (A) differs depending on the type of component (B). Hence, from the standpoint of improving the antiperspirant effect, the duration of the antiperspirant effect and the prevention
3 1 of sweat stains on clothing, and also from the standpoint of the absence of stickiness, the optimal compounding ratios of component (A) with component (B-1) or component (B-2) are as follows.
In cases where component (B-1) is used, the ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5, and preferably from 0.04 to 0.75 by weight. When this ratio is less than 0.02, both the durability of the antiperspirant effect and also the sweat stain on clothing suppressing effect worsen. On the other hand, at more than 5, the antiperspirant effect and durability thereof and the sweat stain suppressing effect worsen. Also, the stability (absence of clouding, absence of settling) of the preparation over an extended period of time worsens depending on the compounding ratio of components (A) and (B-1). From the standpoint of stability, the compounding ratio is preferably from 0.02 to 1.0, and more preferably from 0.04 to 0.5.
In cases where component (B-2) is used, the ratio of component (B-2) to component (A), expressed as (B-2)/(A4), is from 0.05 to 10, and preferably from 0.1 to 1 by weight. At less than 0.05, the durability of the antiperspirant effect and the sweat stain preventing effect worsen, whereas at more than 10, the antiperspirant effect and its durability, as well as the sweat stain on clothing preventing effect, cease to be acceptable, in addition to which the absence of stickiness decreases.
Also, the stability (absence of clouding, absence of settling) of the preparation over an extended period of time worsens depending on the compounding ratio of components (A) and (B-2). From the standpoint of stability, the compounding ratio is preferably from 0.05 to 1.0, and more preferably from 0.1 to 0.5.
EEE ————————— eee errr 3 1 [ (C) Powder]
In this invention, by further including (C) a powder, the antiperspirant effect can be made to last longer and a long-lasting deodorizing effect against body odor due to perspiration can be obtained. Illustrative examples of the powder include magnesia-silica, silica, talc, nylon resin and silicone resin. A single powder may be used alone, or two or more powders may be used in combination.
Of these, from the standpoint of the deodorizing effect and the durability of the antiperspirant effect, magnesia- silica, silica and talc are preferred. The powder has an average particle diameter of preferably from 0.5 to 30 um.
From the standpoint of the durability of the deodorizing effect, the average particle diameter is more preferably from 2 to 25 pum. In this invention, the average particle diameter is a value measured with a laser diffraction-type particle size analyzer (Shimadzu Corporation, SALD-2200).
When component (C) is included, from the standpoint of the durability of the antiperspirant effect and the durability of the deodorizing effect, and especially the durability of the deodorizing effect, the content thereof is preferably from 0.1 to 5 wt %, and more preferably from 0.5 to 3 wt %. At less than 0.1 wt %, the durability of the deodorizing effect and the durability of the antiperspirant effect may be inadequate. At more than 5 wt %, whitening may occur.
In addition to the above components, any known ingredient customarily included in deodorant compositions may be suitably formulated according to the form and purpose of the composition, either singly or as a combination of two or more thereof, in the deodorant composition of the invention, insofar as doing so is not detrimental to the advantageous effects of the invention.
Examples include, for example, fats and oils, waxes,
¥ $ silicone oils, hydrocarbon oils, higher fatty acids, esters, higher alcohols, synthetic ester oils, surfactants, polymeric compounds other than component (B}, antioxidants, pigments, emulsion stabilizers, pH adjustors, astringents other than component (A), preservatives, ultraviolet absorbers, chelating agents, humectants, thickeners, algefacients, anti-inflammatory agents, bactericides, amino acids, vitamins, and various plant extracts.
Illustrative examples of higher fatty acids include stearic acid, linoleic acid, lauric acid, myristic acid, palmitic acid, behenic acid, lanolin acid, oleic acid, undecylenic acid and isostearic acid. These may be used singly or two or more may be used together.
Illustrative examples of esters include decyl oleate, butyl stearate, myristyl myristate, hexyl laurate, isopropyl palmitate, isopropyl myristate, octyldodecyl myristate, hexyldecyl dimethyloctanoate, diethyl phthalate, glycerol monostearate, glycerol trimyristate and cetyl lactate. These may be used singly or two or more may be used together.
Surfactants that may be used include nonionic surfactants, anionic surfactants, cationic surfactants and amphoteric surfactants. Of these, surfactants which do not cause skin conditions are preferred. Illustrative examples include surfactants such as soybean lecithin, egg yolk lecithin, saponin, oligoglycosides, phospholipid biosurfactants, acylpeptide biosurfactants, polyoxyethylene-polyoxypropylene glycol, polyoxyethylene-polyoxypropylene cetyl ether, polyoxyethylene-polyoxypropylene butyl ether, polyoxyethylene coconut oil fatty acid monoethanolamide, polyoxyethylene lauryl ether, triethanolamine polyoxyethylene lauryl ether sulfate, sodium
EE ———————————— errr — 1 3 polyoxyethylene lauryl ether sulfate, polyoxyethylene lauryl ether phosphoric acid, sodium polyoxyethylene lauryl ether phosphate, polyoxyethylene lanolin, polyoxyethylene lanolin alcohol, polyoxypropylene butyl ether, sodium polyphosphate, sorbitan monooleate, polyethylene glycol monooleate, polyoxyethylene sorbitan monooleate, polyethylene glycol monostearate, polyoxyethylene glycerol monostearate, polyoxyethylene sorbitan monostearate, sorbitan monopalmitate, polyoxyethylene sorbitan monopalmitate, sorbitan monolaurate, polyethylene glycol monolaurate, polyoxyethylene sorbitan monolaurate, polyoxyethylene sorbit monolaurate and coconut oil fatty acid diethanolamide. These may be used singly or two or more may be used together.
Illustrative examples of astringents include zinc sulfate, zinc phenolsulfonate, citric acid, tartaric acid, lactic acid, tannic acid and alum. These may be used singly or two or more may be used together.
Illustrative examples of humectants include glycerol, 1,3-butylene glycol, propylene glycol, 3-methyl-1,3- butanediol, 1, 3-propanediol, 2-methyl-1, 3-propanediol, pentaerythritol, hexylene glycol, diglycerol, polyglycerol, diethylene glycol, polyethylene glycol, dipropylene glycol, polypropylene glycol, ethylene glycol monoethyl ether, ethylene glycol monobutyl ether, sorbitol, xylitol, erythritol, mannitol, maltitol, glucose, fructose, galactose, mannose, threose, xylose, arabinose, maltose, trehalose, lactose, raffinose, a-, PB- and y-cyclodextrin, pectin, arabinogalactan, dextrin, dextran, glycogen, ethyl glucoside, hyaluronic acid, sodium hyaluronate, urea, trimethylglycine, arginine, lysine, serine, glycine, alanine, phenylalanine, tyrosine,
B-alanine, threonine, glutamic acid, glutamine,
I ———————— 3 3 asparagine, aspartic acid, cysteine, cystine, methionine, leucine, isoleucine, valine, tryptophan, histidine, taurine and hydrolyzed collagen. These may be used singly or two or more may be used together.
Illustrative examples of polymeric compounds and thickeners include guar gum, locust bean gum, quince seed, galactan, gum arabic, tara gum, pectin, xanthan gum, pullulan, gellan gum, chitin, chitosan, agar, casein, collagen, gelatin, ethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, methyl hydroxypropyl cellulose, soluble starch, methylhydroxypropyl starch, propylene glycol alginate, polyvinyl alcohol (PVA), polyoxyethylene-polyoxypropylene copolymer, (dimethicone/vinyl dimethicone) Cross polymer and cationized cellulose. These may be used singly or two or more may be used together.
The algefacient is not particularly limited, and may be suitably selected according to the intended purpose.
Illustrative examples include l-menthol, l-menthyl glyceryl ether and l-menthyl lactate. These may be used singly or two or more may be used together.
No particular limitation is imposed on embodiments of the deodorant composition of the invention. Application as, for example, a cosmetic material, a drug or a quasi- drug is possible. Use as a personal deodorant composition such as for the underarm area is also possible. The form of the inventive deodorant composition is exemplified by various types, such as that of a solid, semi-solid, gel, liquid or cream, preparation being possible based on the customary methods for these forms. In addition, in the practice of this invention, preparation 1s possible by formulating the respective ingredients in a continuous solvent phase (single layer). Specifically, rendering the deodorant composition of the invention into, for example,
=e =e eee ee meee rrr
J ¥ a roll-on product, gel, lotion, mist, stick, cream, sheet or deodorant foundation is preferred. From the standpoint of the durability of the antiperspirant effect and the durability of the deodorizing effect, a roll-on product, gel, lotion or mist is more preferred.
In particular, applying the composition of the invention to the skin in a water-dissolved state is effective for exhibiting the effects thereof. As liquid- type forms such as roll-on products, gels, lotions and mists, preferred use can be made of roll-on type, gel type and lotion type preparations because they can be closely applied and are able to exhibit highly advantageous effects. The deodorant composition of the invention is preferably rendered into a deodorant composition for filling into a roll-on container, a deodorant product obtained by filling the deodorant composition into a roll- on container, or a liquid antiperspirant deodorant product composed of a deodorant composition and a roll-on container having an applicator ball filled with this composition. A roll-on type preparation is housed in a commonly known roll-on container; the deodorant composition can be applied by transferring the composition to the ball which is rotatably held in a partially exposed state on the container by a holder, and bringing the ball into contact with the skin at the time of use. It is also preferable to render the deodorant composition into the form of a gel which is filled into a bottle-type container and applied directly using the container, or into the form of a gel or lotion which is applied using the fingertips or hand.
The method of preparing the deodorant composition of the invention is not particularly limited and may be suitably selected according to the intended purpose. The deodorant composition can be obtained by mixing components
3 J (A) and (B), and also, where necessary, component (C) and optional ingredients, together with ethanol and water (which are included as the balance of the composition so that the overall amount of deodorant composition becomes 100 wt %).
The invention is illustrated more concretely below by way of Working Examples and Comparative Examples, although the invention is not limited by these Examples. In the
Examples that follow, the amount of each ingredient is shown as the content thereof expressed in terms of the pure ingredient. [Examples 1 to 80 and Comparative Examples 1 to 9]
Deodorant compositions (roll-on) formulated as shown in the tables below were prepared in the usual manner, 40 mL of the respective compositions were filled into roll-on containers having the specifications indicated below, and the evaluations described below were carried out. The results are presented in the tables. <Bottle> Yoshino Kogyosho KK
Material: HDPE Natural Capacity when full approx. 56 mL
Body diameter approx. ¢ 33 mm Height approx. 87 mm <Ring> Yoshino Kogyosho KK
Material: LLDPE Natural Outside diameter approx. 26 mm
Height approx. 18 mm <Ball> Yoshino Kogyosho KK
Material: PP White Diameter approx. 20 mm [Antiperspirant Effect]
Method of Evaluation
EE I —————————————— ree. } i
Each sample was applied in an amount of about 0.1 g to a region (length by width: 3 cm x 3 cm) on the inside of the forearm on 20 female subjects ranging in age from the twenties to thirties. After the samples had dried, the subjects carried out 15 minutes of light exercise in a 35°C, 70% RH environment. Next, the amounts of perspiration in the area where a sample was applied and in an untreated area were measured using a perspiration meter (SKN-200, from Nishizawa Electric Meters Manufacturing
Co., Ltd.), and the antiperspirant ratio was determined from the following formula. The results are indicated as average values for the 20 subjects. [Mathematical Formula 1]
Sweat suppression ratio (%) = 100 - [amount of perspiration (mg/min) in treated area/ amount of perspiration (mg/min) in untreated area] x 100
Rating Criteria ©: Sweat suppression ratio was 81 to 100%
QO: Sweat suppression ratio was 61 to 80%
A: Sweat suppression ratio was 41 to 60% x: Sweat suppression ratio was 0 to 40% [Duration of Antiperspirant Effect (antiperspirant effect after 8 hours)
Method of Evaluation
The durability of the antiperspirant effect was evaluated in 20 female subjects ranging in age from the : twenties to the thirties who use deodorants. Each sample
TE ———— —————————— eee rrr
C 5) was applied as a roll-on preparation in an amount of 0.2 g to the underarm area in the morning, and the amount of perspirant 8 hours later was measured in the same way as described above. The sweat suppression ratio was determined from the above formula. The rating results, So indicate the average value for the 20 subjects. . p < [Absence of Sweat Stains on Clothing, Absence Y: 2, !
Stickiness, Durability of Deodorizing Effect] c
The absence of sweat stains on clothing, the absence . of stickiness and the durability of the deodorizing effegt were evaluated in 20 female subjects ranging in age from the twenties to the thirties who use deodorants. Each sample was applied as a roll-on preparation in an/amount of 0.2 g to the underarm area in the morning, and evaluations were carried out by the following methods. (Absence of Sweat Stains on Clothing)
Method of Evaluation
At the time that the subjects sensed they were perspiring the most, the subjects themselves carried out a visual evaluation of sweat stains on the underarm areas of the T-shirts they were wearing. <Rating Criteria>
Number of subjects who decided that they had no sweat stains. ©: 16 to 20
Oo: 11 to 15
A: 6 to 10 x: 0 to 5 (Absence of Stickiness)
Method of Evaluation
EE ————————————— EE —————————————reeeeeesr error. 1 i
The absence of stickiness following application of the deodorant was evaluated by the subjects themselves.
Rating Criteria
Number of subjects who decided that they were free of stickiness. ©: 16 to 20
OO: 11 to 15
A: 6 to 10 x: 0 to 5 (Durability of Deodorizing Effect)
Method of Evaluation
Each subject applied the roll-on preparation to one underarm area, then put on a T-shirt having prewashed pieces of gauze (5 cm x 5 cm) sewn onto both underarm areas. After the T-shirts had been worn for 8 hours, the shirts were recovered and the worn gauzes were subjected to odor evaluations in which each judge on a five-person panel carried out sensory evaluations for each of the 20 subjects, comparing the gauze at the treated site with the gauze at the untreated site (the underarm on the other, untreated side). The results obtained by calculating the average score of the odor evaluations for 20 pieces of worn gauze were rated according to the criteria indicated below. The subjects were not permitted to use other antiperspirants starting 3 days before application, and were asked to use an unscented body soap on the day prior to application.
Scoring Criteria 5 points: No odor whatsoever compared with untreated site
¥ 1 4 points: Substantially no odor compared with untreated site 3 points: Slight odor compared with untreated site 2 points: Discernible but small odor from untreated site 1 point: Odor is of the same degree or greater than that at untreated site
Rating Criteria ©: At least 4 points and up to 5 points
O: At least 3 points but less than 4 points
A: At least 2 points but less than 3 points x: At least 1 point but less than 2 points
EE ——————————__ - : = [Table 1] meme
Formulation (wt %) elas ee (A) chlorohydroxyaluminum- 2.0 propylene glycol complex ’ chlorohydroxyaluminum/ 2.0 zirconium-glycine complex :
Ammonium (styrene/ alkyl acrylate) copolymer 1.0 1.0 1.0 0.5 1.0 1.0 1.0 (B-1)
Ammonium alkyl acrylate 1.0 copolymer .
Teoprony? nett ehenet 2 or a glyceryl Sher 8 3
Fraronypropyl ceintose o a
Re a Fragrance :
S Frhanet = " Y roritisn ores Lote tannins
Antiperspirant effect : °olojofojojo]o]e ~ 0 FE 0 Durability of 8 3 > Absence of sweat stains
EEE ——————— EE ————————————— eee reer ¥ ’ [Table 2] eee
Formulation (wt $%) oo fue ]n fuse]
Chlorohydroxy- oo |store ooo] 20] 202s] so] 0s] s0] 0 uo)
Ammonium (B~1)| (styrene/alkyl 0.1 2.5 0.5 1.5 0.51 2.0 2.5 0.5 1.0 2.0 acrylate) copolymer
Isopropyl methyl phenol 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1
POP (17) glyceryl 2 ether 1.0 1.0 1.0 1.0 1.0 1.0 1.0 1.0 [1.0 1.0 = o Hydroxypropyl bi o o - o | Fragrance 0.4 :
S Frhanod he " Y roricios voter |e] re] mir] mir] ie] is ire ire rs ire
Antiperspirant n | effect (instrument © © © © © © © © | evaluation) 3 ¢ | Durability of
H | antiperspirant © © © © © © © a effect 5
Y | Absence of [ol 5] Absence of sweat
EEE —————————————————eeeeer eee ¥ + [Table 3] eee
Formulation (wt $%)
EEE
_ Ammonium (styrene/alkyl 1 1.0 (B-1) acrylate) copolymer 1.0 1.0 1.0 1.0 1.0 .0 sressacmities J za | [| Jos] a0 sae Jee en ee a2] ssc sn |] ee)
Teopropy: meth phenol 0
S b Frdroxypropyl celiutose o o --
E
Fehanol o vt * socitied water ten taessnacnmetaes ntre i
Antiperspirant effect meni, [0 [oe [6 | 0000 0
Pp im Durability of 9 2 5 3 Absence of sweat stains £m
Durability of
=P —————— eee eee eee arr err.
Y ' [Table 4]
Comparative Example
Formulation (wt %) eae se] chorenydroxyatuminun 20 | 20 | - | eo woo | ou _ Ammonium (styrene/ 2.5 (B-1) alkyl acrylate) copolymer 1.0 0.1 (Methyl vinyl ether/ maleic anhydride) 1.0 copolymer ' (8) PER (Styrene/isoprene/styrene 1.0 ) block copolymer :
Teopropyt mer phenol § - : yerorypropyt cetiutose o c — a Fragrance = :
S Frhanol oe vt ? rors unter omtece onan tone sce ance stace o Antiperspirant effect © £2 (instrument evaluation) = ¢ | Durability of
H antiperspirant effect § ; -—
E Absence of sweat stains on clothing
I —————————— x + [Table 5] meme
Formulation (wt %) [oo [wm ow] 22 (3) Chlorohydroxyaluminum- 2 propylene glycol complex
Chlorohydroxyaluminum/ 2 zirconium-glycine complex (Acrylates/ (Ci-15) alkyl (B-1) [| acrylate/ (Cy) alkyl 1 1 1 0.5 1 1 1 acrylamide) copolymer AMP reopropy? ret phenol 3 or or glyeeyt Sher § -—
E yarorypropy! cetiutose oO a -— a Fragrance 0.4
E
S Fehanod °° vt Y ee
Antiperspirant effect : o|ojojojofo]e = 0 . o Durability of py antiperspirant effect © ooo] © © © 8 3 > Absence of sweat stains
EE ee ——————— ——— EE {Table 6] ’
Formulation (wt $%) Ce . pl oo ” 4 chiorohydronyatuminin i (Acrylates/ (C,_13) alkyl acrylate/ Vi << (Cig) alkyl acrylamide) copolymer AMP Se (Alkyl acrylate/diacetone : acrylamide) copolymer- 1 amodimethicone /
Octylamide acrylate-hydroxypropyl (B-1) acrylate-butylaminoethyl 1 methacrylate copolymer (Alkyl acrylate/diacetone 1 acrylamide) copolymer AMPD (Alkyl acrylate/diacetone 1 acrylamide) copolymer reopropt rer phenol 2 or tn oryeent erie 8 -~ : arerypropyl eel ulose o c -— o Fragrance :
S Frhaned to " ?
Antiperspirant effect 8 (instrument evaluation) © © © 3 ® | Durability of antiperspirant ©
H effect o 3 3 Absence of sweat stains on © clothing —-0 6
EEE ———————————— eee t £ [Table 7]
Formulation (wt %) aw [we |e _ (Acrylates/ (Cy-15) alkyl acrylate/ (B-1) (Cig) alkyl acrylamide) copolymer AMP 0.1 2.5 0.3 1.5
Teopropy: ret phenol g or or Flyeenyt Sher 8 -~ ; Pyaroxypropyl seuss o a -— a Fragrance :
Antiperspirant effect 8 (instrument evaluation) © © © © 7 : a > antiperspirant srrect oe | 0 | eo o 3 2 g 3 Absence of sweat stains - clothing oe] eo] eo
EE ————————————— eee eee ______
X ¥ [Table 8]
Formulation (wt %)
Shioronydroxyaluminin (Acrylates/ (C;.15) alkyl (B-1)| acrylate/ (Cys) alkyl 0.1 2 2.5 0.5 1 1 acrylamide) copolymer AMP reopropy? ret phenol 2 TF wr grycesyt ether 6 a f ydroxypropyd cellulose g -— :
Antiperspirant effect : o|ojofolejo]e = n 0 Durability of . antiperspirant effect (o]olofoefe|o|e 8 3 > Absence of sweat stains
Even when the ratio in Example 42 was changed to 0.02, the same results as in Example 42 were obtained.
I ———— eer ereemeeeoeer—————____ 1. x } [Table 9]
Formulation (wt $%) [wa waa] (Acrylates/(C;-15) alkyl (B~1) { acrylate/ (Cig) alkyl 1 1 1 1 1 1 1 acrylamide) copolymer AMP
Teopropyt methyl phenol 0) a g pa a Fragrance 2 : 8 Srhanel os ve >
Antiperspirant effect (instrument evaluation) © © © © © © © wn
D
~ Durability of “9 8
A
42 3 Absence of sweat stains o | on clothing © © © © © © © a
EE ———————————————er er. _ i x [Table 10]
Formulation (wt $%)
BEE EERE chiorehydronyaiuminin 2020 [20 | wo fos | anno] 0s] _ (VA/crotonic acid/vinyl neodecanoate) copolymer 0.1 5.0 1.0 oo 5.0 0.5 2.0 2.5
Teopropy: meth phenol : oF or pryeenyt other a b Hyrorypropyt cetiutose o a
A
:
S Frhenel o " Y
Antiperspirant effect 8 (Instrument evaluation) © © © © © | © (oo = 0 Co 0 Durability of 3 i & Absence of sweat stains on clothing (o|o]efefo]o|o]o
EE ————————————————eeeeeeeer——————___.. _ ro & [Table 11]
Formulation (wt $%) crorohydronyaluminun _ (VA/crotonic acid/vinyl (B-2) neodecanoate) copolymer 1.5 2.0 1.0 3.0 recpropyt nett phenot 2 wr tr Flyers: Srher 8 -~ : Fydrorypropy cetiutose o a -— :
Antiperspirant effect a (instrument evaluation) © © © © © 3 wn . o Durability of - antiperspirant effect 8 > Absence of sweat stains x «2 [Table 12]
Formulation (wt %)
EERIE crorehydroxyaiuminen a (VA/crotonic acid/vinyl (B-2) neodecancate) copolymer 1.0 1.0 1.0 1.0 1.0 1.0 1.0 reopropy: methyl phenol 0 a
Pydronypropyt celintose g -— o Fragrance = :
Antiperspirant effect wn
Pp = Durability of pe © a 5 Absence of sweat stains s on clothing © © © © © © ©
I
Durability of
TE ——————————— y ' 4 [Table 13]
Comparative Example
Formulation (wt $%) ee chiorohydroryaluminun EEE (B-2) (VA/crotonic acid/vinyl neodecanoate) copolymer recpropvt rer phenot > slveent srher ydronypropyl celiutose
Common ingredients
Fragrance
Frhanel he ?
Antiperspirant effect © (instrument evaluation)
Durability of antiperspirant effect x | a | oo
Evaluation results
Absence of stickiness
Absence of sweat stains on clothing | x | a ee —————————————— 3 ¢ } [Table 14] eee
Formulation (wt %) en me] = choronydroxyatuninun (Vinyl methyl ether/ethyl maleate) 0.1 copolymer : (B-2) (Vinyl methyl ether/butyl maleate) 0.1 1 3 copolymer : reopropy! rere phenol 2 Fo wr slyceryt erher 8 -— g ydroxypropyl celiutose on a rl :
S Frhenod 0 " ?
EE Ee ee
Antiperspirant effect 3 |Msenasit, | ooo |oe oe 3 a Durability of antiperspirant ©
H effect © 3 g sosence cr suscuiness | 0 | 0 | © | 0 | 0 3 Absence of sweat stains on © clothing [Examples 81 to 98]
The following deodorant compositions (roll-on) formulated as in Examples 26, 31, 32, 40, 41, 45 to 48, 35, 58, 59, 64 to 68 and 80 were prepared in the same way as in these examples. As shown below, the compositions of the invention had excellent preparation stabilities over a long period of time.
a ——— ¥ O 3 [Stability of Preparation]
Method of Evaluation
Each sample in an amount of 40 mL was placed in a glass bottle and the appearance was observed immediately following sample preparation (suitability for compounding: initial stability), after one month of storage at 40°C and 75% RH (stability over time, short-term), and after three months of storage (stability over time, long-term).
Rating Criteria ©: Clear
QO: Substantially clear
A: Slight clouding or turbidity x: Turbidity and/or settling [Table 15] meme
Formulation me ® BEER (Example | (Example | (Example | (Example | (Example 26) 31) 32) 40) 41) ortoromoroatomion | 5 [ws | 0 | 2 | 2 (Acrylates/ (C;-13) alkyl acrylate/ (B-1)| (Cis) alkyl acrylamide) 1 1 1 0.3 1.5 copolymer AMP swoon sem erat | 0x | 0a | oa | oa | oa : 8 -— § g -—
Oo :
O Ethanol (95 wt %) 70 70 70 70 70
EE
EE ————————— es —————_ a iH i
Stability: Suitability for “ compounding © © © © ©
Oo (initial stability) -r joe Co ®'5 | Stability: Over time - short-term:
Sa 10°C, 1 M © © © © © 3 “ © . . .
Stability: Over time - long-term: : 10°¢, 3M 0] ofo |e] oo]
{. «
DEODORANT CC
The present inventi composition.
In recent years, ar uneasy about their body odor, anu for a higher body odor Suppressi... antiperspirants. In order to suppress body odor, - very effective to suppress perspiration, which is an odor- causing substance. Most antiperspirants currently on the market use the sweat gland obstructing action of chlorohydroxyaluminum as the technique for reducing perspiration.
However, it is often the case today that when the amount of perspiration is large, the antiperspirant effect is inadequate and odor becomes a concern.
Prior-art documents relating to this invention are given below.
Patent Documents
Patent Document 1: JP-A 2005-536477
Patent Document 2: JP-A 10-500711
Patent Document 3: JP-A 2004-517093
Patent Document 4: JP-A 8-34718
Patent Document 5: JP-A 2-290810
Patent Document 6: JP-A 2010-70553
Patent Document 7: JP-A 2000-86476
HE ———————————————————— a 0 [Table 16]
Formutation me Y oo | ow [sw (Example | (Example | (Example | (Example | (Example 45) 46) 47) 48) 35) (Acrylates/ (Ci.15) alkyl acrylate/ (C1-3) alkyl acrylamide) 0.5 1 1 copolymer AMP (B-1) (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl 1 methacrylate) copolymer 2 or vr styeesyt ether 5 fs yaronypropyt celintose o o -H : 5 Frhanol oe i ?
Stability: Suitability for compounding © © © © © o (initial stability) © wn an
PP Daa . os | Stability: Over time - short-term:
Aa 40°C, 1 M © © © © ©
Sf = Stabilit O ti 1 t ability: Over time - long-term: 40°C, 3 M © © © © ©
EEE ——————————————
[7] (yd [Table 17]
Formulation ve Y a [a | a | w (Example | (Example | (Example | {Example 58) 59) 64) 65) chiorohydroxyaluninun ee es opoiimer seri ecdeseneate BREE copolymer
Teopropyt ner phenol & or vr gryeeyt ether 8 - § yaronypropyl celtutose o o -— :
S Frhaned 0 " Y
Stability: Suitability for compounding g (initial stability) © © © © oH 0 £5 | stability: over time - short-term: 32 Ye, 1m © © © © — ’ oO
NY
= Stability: Over time - long-term: sie guru semen | 0 | 0 | 0 |e
= ————————— eee eet epee
Eootv [Table 18]
Fomutation me * EERE EE (Example | (Example | (Example | (Example 66) 67) 68) 80) chioronydroxyatuninun (VA/crotonic acid/vinyl neodecanoate) 1 3 copolymer (B-2) (Vinyl methyl ether/butyl maleate) 3 copolymer
Tecpropyt mer phenet 7 oF or sryeenyt Sher § 3 ydronypropyl celiuiose o a -H g
S Frhanet oe " ?
Stability: Suitability for compounding g (initial stability) © © © © or 0 £45 | stability: Over time - short-term: 33 Ygee, 1m © © © © — r 5 0
SH
= Stability: Over time - long-term:
&® £9 3 [Example 99] Deodorant Mist (trigger-type container)
A 100 mL amount of the sample was filled into a trigger-type spray container (average diameter of spray holes: 0.45 mm; trigger: Zz-305, from Mitani Valve Co.,
Ltd.; polyethylene container: PH-100, from Kamimura
Kagaku Kogyo KK), and evaluations were carried out in the same way as described above. [Table 19] !
Chioronydroxyatuminun
Ammonium (styrene/alkyl acrylate) copolymer
Isopropyl methyl phenol
POP (17) glyceryl ether
Hydroxypropyl cellulose
Common ingredients snc es ities wmser | eee
Antiperspirant effect (instrument evaluation)
Evaluation results Durability of antiperspirant effect for pleasantness
Absence of sweat stains on clothing yo) [Examples 100 to 102] Deodorant Gels (bottle-type container)
In each example, 20 mL of the sample was filled into a bottle-type container (TOM-30, with inside plug (Nozzle
B for TO cap)), and evaluations were carried out in the same way as described above. [Table 20]
Formulation (wt $%) chiorohydroxyaluninun BIIEX (Acrylates/ (Ci.14) alkyl acrylate/ 0.7 0.5 (C15) alkyl acrylamide) copolymer AMP : : (B-1) (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) 0.5 copolymer
Stearyl trimethylammonium chloride (50 wt $%)
Aydroxypropyl cellulose
Common ingredients
Fragrance 0.3 0.3
Ethanol os vt ¥ : Antiperspirant effect (instrument evaluation)
Evaluation Durability of antiperspirant effect results for pleasantness of use Absence of stickiness © © ©
Absence of sweat stains on clothing
Suitability for compounding } (initial stability) © © ©
Evaluation fesults Over time - short-term: 40°C, 1 M stability over time } Long-term: 1c, > "
Se - iL -» [Example 103] Deodorant Lotion (bottle-type container)
The sample in an amount of 40 mL was filled into a bottle-type container (TOMIII-50, with inside plug (Nozzle
A for TO cap)), and evaluations were carried out in the same way as described above. [Table 21] 1
Formulation (wt $%) Be © chiorofydroxyaluninum (Acrylates/(Ci.13) alkyl acrylate/ (Cg) alkyl acrylamide) (B-1) 0.5 copolymer AMP
Isopropyl methyl phenol
POP (17) glyceryl ether
Hydroxypropyl cellulose
Common ingredients
Fragrance 0.5
Ethanol (95 wt %)
Antiperspirant effect (instrument evaluation)
Evaluation Durability of antiperspirant effect results for pleasantness of use Absence of stickiness ©
Absence of sweat stains on clothing ; Suitability for compounding (initial stability)
Evaluation results for Over time - short-term: 40°C, 1 M © stability
Over time - long-term: 40°C, 3 M
[JE 4)
Details on the starting materials used in the
Examples and the Comparative Examples are given in the following table. [Table 22] 5 5 Trade Ingredient
Armonium (styrene/alkyl acrylate) Yodosol 45 wt % copolymer GH41F AkzoNobel Japan aqueous solution
Ammonium alkyl acrylate Yodosol 45 wt %
GHB OOF Alzotionel Japan aqueous solution (Acrylates/ (Ci-15) alkyl acrylate/ . . AMP-neutralized (Cys) alkyl acrylamide) Plascize Goo Chemical 40 wt % copolymer AMP 0. : ethanol solution (Acrylates/ (Ci) alkyl acrylate/ Plus size 1-9909B . (Ci-g) alkyl acrylamide) copolymer was desalinated using 1-8 polym hydrochloric acid (Alkyl acrylate/diacetone acrylamide) SETSIL314 Dow Corning 2 t/a ueous copolymer-amodimethicone Toray Co., Ltd. solution a (Octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl Pa pEONER AkzoNobel Japan methacrylate) copolymer (Alkyl acrylate/diacetone Plascize Goo Chemical AMPD-neutralized acrylamide) copolymer AMPD L-1260 Co., Ltd. ethanol solution (Alkyl acrylate/ Plascize Goo Chemical 50 wt $% diacetone acrylamide) copolymer | L-53 Co., Ltd. ethanol solution (VA/crotonic acid/ RESYN vinyl neodecanocate) copolymer 28-2930 AkzoNobel Japan (Vinyl methyl ether/ Gantrez ISP ethyl maleate) copolymer ES-225 (Vinyl methyl ether/ Gantrez 1p butyl maleate) copolymer ES-425 . os Mizusawa
Magnesia-silica , : ; : Mizupearl Industrial (average particle Stee. ’ um) isons Chemicals, Ltd.
Silica porous particles Sunsphere AGC Si-Tech (average particle size, 12 um) H122 Co., Ltd.
Talc i (average particle size, 24 pm) Aoada seifun IE
Silicone powder Tospearl . (average particle size, > pm) 150 KA ones
Non-porous nylon beads Mukoshitsu | Miyoshi Kasei, (average particle size, 5 um) Nylon 12 Inc. (Methyl vinyl ether/ Gantrez ISP maleic anhydride) copolymer AN-119 (Styrene/isoprene/styrene) Cariflex . block copolymer TR1111 Shell Chemical
§ A
It is therefore an object of this invention to provide a deodorant composition which has a satisfactory antiperspirant effect that is also long-lasting, holds down stickiness, 1s able to prevent sweat 'stains on clothing and moreover has a long-lasting deodorizing effect against body odor due to perspiration.
The inventors have conducted extensive investigations, as a result of which they have discovered that by using together both an antiperspirant component and a specific anionic polymer, an increased antiperspirant effect is achieved and this antiperspirant effect lasts a long time, in addition to which stickiness is suppressed and sweat stains on clothing can be prevented. Moreover, the inventors have found that by adding also a powder, a deodorant composition that has a long-lasting deodorizing effect against body odor due to perspiration can be obtained.
Accordingly, the invention provides the following deodorant composition.
[1] A deodorant composition characterized by including: (A) an antiperspirant component, and (B-1) an acrylic acid-based anionic polymer selected from among an ammonium (styrene/alkyl acrylate) copolymer, an ammonium alkyl acrylate copolymer, an (octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) copolymer, an (alkyl acrylatg/diacetone acrylamide) copolymer-amodimethicone, an (acrylates/(Cji-1g) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer or a salt
EEE —— EE ——— er ere er ————————— { «
DEODORANT COMPOSITION
The present invention relates to a deodorant composition.
In recent years, an increasing number of people feel uneasy about their body odor, and so there exists a desire for a higher body odor suppressing effect in antiperspirants. In order to suppress body odor, it is very effective to suppress perspiration, which is an odor- causing substance. Most antiperspirants currently on the market use the sweat gland obstructing action of chlorohydroxyaluminum as the technique for reducing perspiration.
However, it is often the case today that when the amount of perspiration is large, the antiperspirant effect is inadequate and odor becomes a concern.
Prior-art documents relating to this invention are given below.
Patent Documents
Patent Document 1: JP-A 2005-536477
Patent Document 2: JP-A 10-500711
Patent Document 3: JP-A 2004-517093
Patent Document 4: JP-A 8-34718
Patent Document 5: JP-A 2-250810
Patent Document 6: JP-A 2010-70553
Patent Document 7: JP-A 2000-86476
I A thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof; wherein the weight ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.
[2] The deodorant composition of [1], wherein the salt of an (acrylates/(C;-18) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer is the 2-amino-2-methyl-l-propanol salt of an (acrylates/(Ci-13) alkyl acrylate/(Ci-g) alkyl acrylamide) copolymer, and the salt of an (alkyl acrylate/diacetone acrylamide) copolymer is the 2-amino-2-methyl-1, 3- propanediol salt of an (alkyl acrylate/diacetone acrylamide) copolymer.
[3] The deodorant composition of [1] or [2], wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-1) is from 0.3 to 2 wt % of the overall composition.
[4] A deodorant composition characterized by including: (A) an antiperspirant component, and (B-2) a vinyl acetate-based anionic polymer selected from among a (vinyl acetate/crotonic acid/vinyl neodecanocate) copolymer, a (vinyl methyl ether/ethyl maleate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer; wherein the weight ratio of component (B-2) to component (A), expressed as (B-2)/(A), is from 0.05 to 10.
[5] The deodorant composition of [4], wherein component (B-2) is a (vinyl acetate/crotonic acid/vinyl neodecanocate) copolymer.
[6] The deodorant composition of [4] or [5], wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-2) is from 1 to 4 wt % of the overall composition.
[7] The deodorant composition of any one of [1] to [6], wherein component (A) is chlorohydroxyaluminum.
a ———————————— EE ————
X x
[8] The deodorant composition of any one of [1] to [7] which further comprises (C) a powder.
[9] The deodorant composition of [8], wherein component (C) is a powder selected from among talc and magnesia- silica.
This invention is able to provide a deodorant composition which has a high antiperspirant effect and maintains the antiperspirant effect for a long time, holds ! down stickiness, and can prevent sweat stains on clothing.
This invention is able to provide also a deodorant composition which, in addition to these qualities, has moreover a long-lasting deodorizing effect against body odor due to perspiration.
[{(A) Antiperspirant Component]
The antiperspirant component is not subject to any particular limitation, provided it is a component that imparts an antiperspirant effect. Illustrative examples include aluminum chloride, aluminum sulfate, aluminum potassium sulfate, aluminum acetate, chlorohydroxyaluminum, allantoin chlorohydroxyaluminum, chlorohydroxyaluminum-propylene glycol complexes and chlorohydroxyaluminum/zirconium-glycine complexes. These may be used singly or two or more may be used in combination. Of these, from the standpoint of the antiperspirant effects, chlorohydroxyaluminum, a chlorohydroxyaluminum-propylene glycol complex or a chlorohydroxyaluminum/zirconium-glycine complex is preferred. Chlorohydroxyaluminum is especially preferred.
EE ———————— eee ere. 1 3
The content of component (A), from the standpoint of the antiperspirant effect, is preferably from 0.1 to 15 wt %, and more preferably from 1.5 to 10 wt %, of the overall composition. At less than 0.1 wt %, the antiperspirant effect and its durability, and also the sweat stain suppressing effect, may be inadequate. On the other hand, a content of more than 15 wt % may lead to a decline in the absence of stickiness, a worsening of skin irritation or inferior stability (absence of clouding, absence of settling) of the preparation. [(B) Anionic Polymer]
An anionic polymer is formulated in order to, through interaction with the antiperspirant component (7), increase the antiperspirant effect and prevent sweat stains on clothing. As this anionic polymer, preferred use can be made of (B-1) an acrylic acid-based polymer or (B-2) a vinyl acetate-based polymer. (B-1) Acrylic Acid-Based Anionic Polymer
The acrylic acid-based anionic polymer is exemplified by an ammonium (styrene/alkyl acrylate) copolymer (trade name: Yodosol GH41lF, available from AkzoNobel Japan, 45 wt %), an ammonium alkyl acrylate copolymer (trade name:
Yodosol GH800F, available from AkzoNobel Japan, 45 wt %), an (octylamide acrylate/hydroxypropyl acrylate/butylaminoethyl methacrylate) copolymer (trade name: AMPHOMER 28-4910, available from AkzoNobel Japan), an (alkyl acrylate/diacetone acrylamide) copolymer- amodimethicone (chemical name: mixture of alkyl acrylate- alkyl methacrylate-diacetone acrylamide-methacrylic acid copolymer and aminoethylaminopropylmethylsiloxane- dimethylsiloxane copolymer; trade name: SETSIL314, from
Dow Corning Toray Co. Ltd., 20 wt $%), (acrylates/(Ci-1s)
Claims (20)
1. A deodorant composition characterized by comprising: (A) 0.1 to 15 wt% of an antiperspirant component, and a : (B-1) 0.1 to 2.5 wt$% of an acrylic acid-based anionid) J polymer selected from among an ammonium (styrene/alkyl Tf, acrylate) copolymer, an ammonium alkyl acrylate copolymer, "py an octylamide acrylate-hydroxypropyl acrylate- <P butylaminoethyl methacrylate copolymer, an (afYky acrylate/diacetone acrylamide) copolymer-amodimethifcone, an (acrylates/(Cj-13) alkyl acrylate/(Ci-g) alkyl acry amide) copolymer or a salt thereof, and an (alkyl acrylate/diacetone acrylamide) copolymer or a salt thereof; wherein the weight ratio of component (B-1) to component (A), expressed as (B-1)/(A), is from 0.02 to 5.
2. The deodorant composition of claim 1, wherein the salt of an (acrylates/(Ci-13) alkyl acrylate/ (Cig) alkyl acrylamide) copolymer is the 2-amino-2-methyl-l-propanol salt of an (acrylates/(Ci-13) alkyl acrylate/(Ci-s) alkyl acrylamide) copolymer, and the salt of an (alkyl acrylate/diacetone acrylamide) copolymer is the 2-amino-2- methyl-1,3-propanediol salt of an (alkyl acrylate/diacetone acrylamide) copolymer.
3. The deodorant composition of claim 1 or 2, wherein the content of component (A) is from 1.5 to 10 wt % of the overall composition and the content of component (B-1) is from 0.3 to 2 wt % of the overall composition.
4. The deodorant composition of claim 1 or 2, wherein component (A) is chlorohydroxyaluminum.
5. The deodorant composition of claim 1 or 2 which further comprises (C) a powder.
6. The deodorant composition of claim 5, wherein component (C) is a powder selected from among talc and magnesia-silica.
7. The deodorant composition of claim 5, wherein the content of component (C) is 0.1 to 3 wt% of the overall composition.
8. The deodorant composition of claim 1 or 2 which is in gel or liquid form.
9. The deodorant composition of claim 1 or 2 which contains water and the content thereof is 12.2 to 27.85 wt%.
10. The deodorant composition of claim 1 or 2 which is to be filled in a roll-on, gel, lotion or mist container.
11. A deodorant composition characterized by comprising: (A) 0.1 to 15 wt% of an antiperspirant component, and (B-2) 0.1 to 5 wt% of a vinyl acetate-based anionic polymer selected from among a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer, a (vinyl methyl ether/ethyl maleate) copolymer and a (vinyl methyl ether/butyl maleate) copolymer; wherein the weight ratio of component (B-2) to component (A), expressed as (B- 2)/(A), is from 0.05 to 10.
12. The deodorant composition of claim 11, wherein component (B-2) is a (vinyl acetate/crotonic acid/vinyl neodecanoate) copolymer.
13. The deodorant composition of claim 11 or 12, wherein the content of component (A) is from 1.5 to 10 wt% of the overall composition and the content of component (B-2) is from 1 to 4 wt% of the overall composition.
14. The deodorant composition of claim 11 or 12, wherein component (A) is chlorohydroxyaluminum.
15. The deodorant composition of claim 11 or 12 which further comprises (C) a powder.
16. The deodorant composition of claim 15, wherein component (C) is a powder selected from among talc and magnesia-silica.
17. The deodorant composition of claim 15, wherein the content of component (C) is 0.1 to 13 wt% of the overall composition.
18. The deodorant composition of claim 11 or 12 which is in gel or liquid form.
19. The deodorant of composition of claim 11 or 12 which contains water and the content thereof is 12.2 to 27.85 wts.
20. The deodorant composition of claim 11 or 12 which is to be filled in a roll-on, gel, lotion or mist container.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011260213 | 2011-11-29 | ||
PCT/JP2012/080941 WO2013081055A1 (en) | 2011-11-29 | 2012-11-29 | Deodorant composition |
Publications (2)
Publication Number | Publication Date |
---|---|
PH12014501211A1 PH12014501211A1 (en) | 2014-09-08 |
PH12014501211B1 true PH12014501211B1 (en) | 2014-09-08 |
Family
ID=48535504
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PH12014501211A PH12014501211B1 (en) | 2011-11-29 | 2014-05-29 | Deodorant composition |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6070571B2 (en) |
MY (1) | MY165096A (en) |
PH (1) | PH12014501211B1 (en) |
WO (1) | WO2013081055A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6452396B2 (en) * | 2013-11-14 | 2019-01-16 | ライオン株式会社 | Antiperspirant composition |
FR3015269B1 (en) * | 2013-12-20 | 2016-01-01 | Oreal | COMPOSITION COMPRISING A PARTICULAR ACRYLIC COPOLYMER AND A POLYMER FIXING AMPHOTERE |
EP3082967A2 (en) * | 2013-12-20 | 2016-10-26 | L'oreal | Composition comprising a specific acrylic copolymer and a fixing polymer chosen from anionic fixing polymers comprising crotonic acid as a monomer, non ionic and non silicone fixing polymers, and amphoteric fixing polymers |
JP6594759B2 (en) * | 2015-12-11 | 2019-10-23 | ライオン株式会社 | Antiperspirant composition |
JP6660258B2 (en) * | 2016-06-20 | 2020-03-11 | ライオン株式会社 | Antiperspirant composition |
JP6900122B2 (en) * | 2018-03-16 | 2021-07-07 | 株式会社マンダム | Antiperspirant composition and antiperspirant |
WO2019176265A1 (en) * | 2018-03-16 | 2019-09-19 | 株式会社マンダム | Antiperspirant composition, and antiperspirant |
JP7393925B2 (en) * | 2019-11-25 | 2023-12-07 | 花王株式会社 | Skin external preparations |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8404844D0 (en) * | 1984-02-24 | 1984-03-28 | Unilever Plc | Skin treatment composition |
IL105748A0 (en) * | 1992-05-22 | 1993-09-22 | Int Research & Dev Corp | Topical antiperspirant composition |
US5534245A (en) * | 1994-02-22 | 1996-07-09 | Helene Curtis, Inc. | Antiperspirant deodorant compositions |
JP2889377B2 (en) * | 1995-11-21 | 1999-05-10 | シチズン時計株式会社 | Driving circuit for inkjet head and driving method thereof |
JP3686756B2 (en) * | 1998-03-31 | 2005-08-24 | 株式会社資生堂 | Antiperspirant |
GB0213999D0 (en) * | 2002-06-18 | 2002-07-31 | Unilever Plc | Antiperspirant emulsion compositions |
US7404946B2 (en) * | 2003-11-21 | 2008-07-29 | The Procter And Gamble Company | Antiperspirant methods and compositions |
JP4493449B2 (en) * | 2004-09-02 | 2010-06-30 | 三菱鉛筆株式会社 | Eye makeup cosmetics |
JP2009292772A (en) * | 2008-06-05 | 2009-12-17 | Mandom Corp | Eyelash cosmetic |
JP5502368B2 (en) * | 2009-05-28 | 2014-05-28 | 花王株式会社 | hair spray |
CN102596168A (en) * | 2009-08-31 | 2012-07-18 | 株式会社资生堂 | Cosmetic preparation for hair styling |
JP2011126862A (en) * | 2009-11-18 | 2011-06-30 | Lion Corp | Cosmetic |
FR2954151B1 (en) * | 2009-12-17 | 2012-03-16 | Oreal | USE OF A COSMETIC COMPOSITION COMPRISING AT LEAST ONE FILMOGENEOUS ELASTOMERIC POLYMER FOR THE TREATMENT OF HUMAN TRANSPIRATION |
JP2011157285A (en) * | 2010-01-29 | 2011-08-18 | Re & Do Kk | Hair growing tonic |
-
2012
- 2012-11-29 JP JP2013547213A patent/JP6070571B2/en active Active
- 2012-11-29 WO PCT/JP2012/080941 patent/WO2013081055A1/en active Application Filing
- 2012-11-29 MY MYPI2014001370A patent/MY165096A/en unknown
-
2014
- 2014-05-29 PH PH12014501211A patent/PH12014501211B1/en unknown
Also Published As
Publication number | Publication date |
---|---|
JP6070571B2 (en) | 2017-02-01 |
PH12014501211A1 (en) | 2014-09-08 |
JPWO2013081055A1 (en) | 2015-04-27 |
WO2013081055A1 (en) | 2013-06-06 |
MY165096A (en) | 2018-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12014501211B1 (en) | Deodorant composition | |
KR101795896B1 (en) | Body odor suppressing agent | |
JP6452396B2 (en) | Antiperspirant composition | |
JP5895478B2 (en) | Liquid-based sweat deodorant composition and liquid-based sweat deodorant product | |
JP5550863B2 (en) | Cosmetics | |
US20120184628A1 (en) | O/w type cosmetic composition with improved dosage form stability | |
JP2021035997A (en) | Odor gas reducing agent | |
JP2017048140A (en) | Antiperspirant composition | |
JP5825053B2 (en) | Liquid-based sweat deodorant composition | |
CN111182885A (en) | Dust control composition | |
KR102062200B1 (en) | Scalp composition, scalp cosmetic and coating method | |
JP6900122B2 (en) | Antiperspirant composition and antiperspirant | |
JP2017122059A (en) | Body odor suppressing agent | |
JP6618401B2 (en) | Emulsion odor control agent | |
JP6284437B2 (en) | Body odor suppressor | |
JP6900121B2 (en) | Antiperspirant composition and antiperspirant | |
JP6660258B2 (en) | Antiperspirant composition | |
JP6613123B2 (en) | Antiperspirant deodorant composition | |
JP6895584B2 (en) | Powder-containing body odor suppressant | |
JP6909353B2 (en) | Powder-containing external preparation for skin | |
JP7475785B2 (en) | Oil-in-water emulsion composition | |
CA3001437A1 (en) | Anti-perspirant composition | |
WO2021085059A1 (en) | Antiperspirant composition | |
JP2022080515A (en) | Antiperspirant composition | |
JP2014218475A (en) | Antiperspirant composition |